Official ESCRS | European Society of Cataract & Refractive Surgeons

Cystoid macular oedema after cataract surgery

Session Details

Session Title: Cataract 2
Session Date/Time: Saturday 21/02/2015 | 08:30-11:00
Paper Time: 08:57
Venue: Hall 1
First Author: : R.Johnston UK
Co Author(s): :    C. Chu              

Abstract Details


To report the incidence of post-cataract surgery cystoid macular oedema (CMO) in all eyes, eyes of patients with diabetes without retinopathy and eyes with retinopathy.


A single centre electronic medical record database study, at a centre that does not use non-steroidal anti-inflammatory prophylaxis. Gloucestershire Hospitals NHS Foundation Trust, Cheltenham General Hospital, Sandford Road, Cheltenham, GL53 7AN.


The Royal College of Ophthalmologists’ Cataract National Dataset was prospectively collected within an electronic medical record (EMR) system (Medisoft Ophthalmology, Leeds, UK) after consecutive cataract operations. Data collection included: pupil size, additional procedures performed and compulsory reporting of the presence or absence of operative and post-operative complications. Automated audit reports within the EMR were used to report the incidence of cystoid macular oedema in different cohorts of patients.


The overall incidence of post-operative CMO was 2.2% after 12,474 cataract operations, increasing to 5.1% in eyes of patients with diabetes and 11.2% in eyes with diabetic retinopathy pre-operatively.


Diabetes and the presence of diabetic retinopathy substantially increase the incidence of post-operative cystoid macular oedema. Highlighting the need for prophylactic treatment

Financial Disclosure:

One or more of the authors research is funded, fully or partially, by a competing company, One or more of the authors travel has been funded, fully or partially, by a competing company

Back to previous